Skip to main content

Animations

MJFF Publications

5451 - 5460 of 8808 Results
Title
Year
  • Year
  • 2015
  • 2022
  • 2017
  • 2021
  • 2025
  • 2018
  • 2020
  • 2016
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: Current disease modifying approaches to treat Parkinson’s disease
    Journal Name: Cellular and Molecular Life Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01318-7
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesia
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.14104
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.633645
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brain
    Journal Name: Neuroepigenetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0153-4
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Dual-Task Performance in GBA Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2017/8582740
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.